亚伯体育

叶洪涛 博士

科室: 病理科·广西临床病理质量控制中心  添加时间: 2019-05-19

 叶洪涛教授,主任医师,博士,毕业于国伦敦大学医学院病理系国家自然科学基金评委中华病理学杂志特邀海外编委,英国质控UKAS (United Kingdom Accreditation Service)评委,大不列颠-爱尔兰病理学会会员欧洲MALT淋巴瘤研究会会员中华医学会会员多次获得广西高校科技进步二等奖广西科学技术进步三等奖。曾在皇家国立骨科医院病理科工作,英国质控UKAS (United Kingdom Accreditation Service)评委。主持和参与基金项目共8项。The Lancet(柳叶刀), American Journal of Pathology(美国病理学杂志), Blood(血液)以及 Gastroenterology(胃肠道学)等国际权威性的杂志上发表过多篇SCI

出版物:

1. Christopher D. Steele, Maxime Tarabichi, Ludmil B. Alexandrov, Dahmane Oukrif, Hongtao Ye, Matthew Fittall, Patrick Lombard, Iñigo Martincorena, Patrick S. Tarpey, Grace Collord, Sandra Strauss1, Fitim Berisha, Marnix Jansen1, Sam Behjati, M Fernanda Amary, Roberto Tirabosco, Peter J. Campbell, Peter Van Loo, Adrienne M. Flanagan, Nischalan Pillay. Undifferentiated sarcomas develop through distinct tumour evolutionary pathways. Cancer Cell 2019;35(3):441-456   5 year impact factor: 22.844 (2017/2018), 27.407 (2016), 23.214 (2015), 23.523 (2014), 23.893 (2013).

2. Matthew Fittall, William Mifsud, Nischalan Pillay, Hongtao Ye, Anna-Christina Strobl, Annelien Verfaillie, Jonas Demeulemeester, Lei Zhang,  Fitim Berisha, Maxime Tarabichi, Matthew Young, Elena Miranda, Patrick Tarpey, Roberto Tirabosco, M Fernanda Amary, Agamemnon Grigoriadis,  Michael Stratton, Peter Van Loo, Christina Antonescu, Peter Campbell,  Adrienne Flanagan. Recurrent rearrangements of FOS and FOSB define osteoblastoma. Nature Communications 2018;9(1):2150  5 year impact factor: 12.353 (2017/2018), 12.124 (2016), 11.329 (2015), -NA- (2014), 10.742 (2013).

3. Sam Behjati, Patrick S Tarpey, Kerstin Haase, Hongtao Ye, Matthew D Young, Ludmil B Alexandrov, Sarah J Farndon, Grace Collord, David C Wedge, Inigo Martincorena, Susanna L Cooke, Helen Davies, William Mifsud, Lidgren Mathias, Sancha Martin, Calli Latimer, Mark Maddison, Adam P Butler, Jon W Teague, Nischalan Pillay, Adam Shlien, Ultan McDermott, P Andrew Futreal, Fernanda Amary, Roberto Tirabosco, Peter Van Loo, Michael R Stratton, Adrienne M Flanagan, and Peter J Campbell. Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma. Nature Communications 2017;8:15936. 5 year impact factor: 12.353 (2017/2018), 12.124 (2016), 11.329 (2015), -NA- (2014), 10.742 (2013).

4. Fernanda Amary, Fitim Berisha, Hongtao Ye, Manu Gupta, Alice Gutteridge, Daniel Baumhoer, Rebecca Gibbons, Roberto Tirabosco, Paul O’Donnell, Adrienne M Flanagan. H3F3A (Histone 3.3) G34W immunohistochemistry:  a reliable marker defining benign and malignant giant cell tumour of bone.  American Journal of Surgical Pathology 2017;41(8):1059-1068. 5 year impact factor: 5.363 (2016/2017), 4.951 (2015), 5.145 (2014), 4.592 (2013), 4.868 (2012).

5. Nadege Presneau, Laure Alice Duhamel1, Hongtao Ye, Roberto Tirabosco, Adrienne M Flanagan and Malihe Eskandarpour. Post-translational regulation contributes to the loss of LKB1 expression through SIRT1 deacetylase in osteosarcoma. British Journal of Cancer 2017;117(3):398-408. 5 year impact factor: 6.176 (2016/2017), 5.569 (2015), 4.836 (2014), 4.817 (2013), 5.082 (2012).

6. Susanne Scheipl, Michelle Barnard, Lucia Cottone, Mette Jorgensen, David H. Drewry, William J. Zuercher, Fabrice Turlais, Hongtao Ye, Ana P. Leite, James A Smith, Andreas Leithner, Peter Möller, Silke Brüderlein, Nischalan Pillay, Fernanda Amary, Roberto Tirabosco, Sandra J. Strauss, Naomi Guppy, Adrienne M. Flanagan. EGFR inhibitors Identified as a Potential Treatment for Chordoma in a Focused Compound Drug Screen. Journal of Pathology 2016;239(3):320-324. 5 year impact factor: 6.894 (2016/2017), 7.381 (2015), 7.429 (2014), 7.33 (2013), 7.585 (2012).

7. JIANG Yi, YE Xinqing, LIAO Xiaoming, JI Yinan, TANG Wei, YE Hongtao. Relation between expression of TOP2A in breast cancer and anthracycline-based neoadjuvant chemotherapy. China Medical Herald 2016;13(35):16-20. (corresponding author) (paper in Chinese). 5 year impact factor: not available.

8. Xingqing Ye, Xiaocong Kuang, Changhong Wei, Junqi Huang, Hongtao Ye.  Clinical study of molecular markers and COL1A1/PDGFB fusion gene in dermatofibrosarcoma protuberans. Chinese Journal of Clinical Oncology 2015;42(21):1042-1046. (corresponding author) (paper in Chinese). 5 year impact factor: not available.  

9. Xianglan Mo, Wenwen Guo, Hongtao Ye. Primary indeterminate dendritic cell tumor of skin correlated to mosquito bite: a case report. Medicine 2015;94(34):e1443.  5 year impact factor: 1.803 (2016/2017), 1.206 (2015), 5.723 (2014), 4.867 (2013), 4.233 (2012).

10. Sangeetha N Kalimuthu, Charles Tilley, Georgina Forbes, Hongtao Ye, Katie Lehovsky, Nischalan Pillay, Beatrice M Seddon, Paul O'Donnell, Robin Pollock,  Roberto Tirabosco, M Fernanda Amary and Adrienne M. Flanagan. Clinical outcome in patients with peripherally-sited atypical lipomatous tumours and dedifferentiated liposarcoma. Journal of Pathology: Clinical Research 2015;1(2):106-112. 5 year impact factor: not available.  

11. Nadège Presneau, Daniel Baumhoer, Nischalan Pillay, Sam Behjati, Patrick Tarpey, Peter J Campbell, Gernnot Jundt, Rifat Hamoudi, David C. Wedge, Peter Van Loo, A. Bassim Hassan, Bhavisha Khatri, Hongtao Ye, Roberto Tirabosco, Fernanda M Amary, Adrienne M Flanagan.  Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast-rich mimics. Journal of Pathology: Clinical Research 2015;1(2):113-123. 5 year impact factor: not available.  

12. Kun Gao, Menglan Eurasian, Jieqing Zhang, Yuluan Wei, Qian Zheng, Hongtao Ye, Li Li. Can genomic amplification of human telomerase gene and C-MYC in liquid-based cytological specimens be used as a method for opportunistic cervical cancer screening? Gynecologic and Obstetric Investigation 2015;80(3):153-163. (corresponding author). 5 year impact factor: 1.415 (2016/2017), 1.672 (2015), -NA- (2014), 1.251 (2013), 1.103 (2012).

13. M Fernanda Amary, Hongtao Ye, Georgina Forbes, Stephen Damato, Francesca Maggiani, Robin Pollock, Roberto Tirabosco, Adrienne Flanagan. Isocitrate dehydrogenase 1 mutations (IDH1) and p16/CDKN2A copy number change in conventional chondrosarcomas. Virchows Archiv 2015;466(2):217-222. 5 year impact factor: 2.848 (2016/2017), 2.613 (2015), 2.651 (2014), 2.56 (2013), 2.676 (2012).

14. Peir-In Liang, Sheng-Tsung Chang, Ming-Yen Lin, Yen-Chuan Hsieh, Pei-Yi Chu, Chih-Jung Chen, Kai-Jen Lin, Yun-Chih Jung, Wei-Shou Hwang, Wen-Tsung Huang, Wei-Chin Chang, Hongtao Ye, Shih-Sung Chuang. Angioimmunoblastic T-cell Lymphoma in Taiwan Showed a Frequent Gain of ITK Gene. International Journal of Clinical and Experimental Pathology 2014;7(9):6097-6107 (corresponding author). 5 year impact factor: 1.706 (2016/2017), 1.581 (2015), -NA- (2014), 1.783 (2013), 2.242 (2012).

15. Liu Lili, Chen Yunxin, Ye Xinqing, Wei Changhong, Ye Hongtao, Guo Wei, Shen Danhua. Clinicopathological and molecular genetic features of rhadomyosarcoma. Orthopedic Journal of China 2014;22(17):1542-1546. (corresponding author) (paper in Chinese). 5 year impact factor: not available.

16. Chen Jun, Ye Xingqing, Li Yao, Wei Changhong, Zheng Qian, Zhong Ping, Wu Shengming, Luo Yuan, Liao Zhiling, Ye Hongtao. Chromosomal translocation involving USP6 gene in nodular fasciitis. Chinese Journal of Pathology 2014;43(8):533-536. (corresponding author) (paper in Chinese). 5 year impact factor: not available.

17. Zeng Lixia, Huang Junqi, Ma YunLiu Yixiao, Wei Yuying, Zheng Qian, Ye Hongtao. Delay in formalin fixation and HER2 testing in gastric cancer. Chinese Journal of Pathology 2014;43(7):468-472. (corresponding author). (paper in Chinese). 5 year impact factor: not available.

18. M. Fernanda Amary, Hongtao Ye, Fitim Berisha; Bhavisha, Georgina Forbes, Katie Lehovsky, Anna M. Frezza, Sam Behjati, Patrick Tarpey, Nischalan Pillay, Peter Campbell, Roberto Tirabosco, Nadege Presneau, Sandra Strauss, Adrienne Flanagan. Fibroblastic Growth Factor Receptor 1 amplification occurs in osteosarcomas which respond poorly to neo-adjuvant chemotherapy. Cancer Medicine 2014;3(4):980-987. 5 year impact factor: 3.362 (2016/2017), 2.915 (2015), -NA- (2014), -NA- (2013), -NA- (2012).

19. Feijun Luo, George Poulogiannis, Hongtao Ye, Rifat Hamoudi, Gehong Dong, Wenyan Zhang, Ashraf EK Ibrahim,Mark J Arends. Wild-type K-ras has a tumour suppressor effect on carcinogen-induced murine colorectal adenoma formation. International Journal of Experimental Pathology 2014;95(1):8-15.  5 year impact factor: 1.706 (2016/2017), 1.581 (2015), -NA- (2014), 1.783 (2013), 2.242 (2012).

20. T.G. Kashima, N.M. Gamage, H. Ye, M.F. Amary, A.M. Flanagan, S.J. Ostlere, N.A. Athanasou. Locally aggressive fibrous dysplasia. Virchows Archiv 2013;463(1):79-84.  5 year impact factor: 2.848 (2016/2017), 2.613 (2015), 2.651 (2014), 2.56 (2013), 2.676 (2012).

21. Hongtao Ye, M. Fernanda Amary, Fitim Berisha, Roberto Tirabosco, Nadege Presneau, Adrienne M. Flanagan. Detection of USP6 gene rearrangement in nodular fasciitis: an important diagnostic tool. Virchows Archiv 2013;463(1):97-98. 5 year impact factor: 2.848 (2016/2017), 2.613 (2015), 2.651 (2014), 2.56 (2013), 2.676 (2012).

22. Roberto Tirabosco, Fitim Berisha, Hongtao Ye, Dina Halai, M Fernanda Amary and Adrienne M Flanagan. Assessment of MUC4 expression in primary bone tumours. Histopathology 2013;63(1):142-143. 5 year impact factor: 3.523 (2016/2017), 3.425 (2015), 3.453 (2014), 3.301 (2013), 2.857 (2012).

23. Janelyn A.L. Dy, Shang-Wen Chen, Sheng-Tsung Chang, Szu-Yin Kuo,  Hongtao Ye, Fatheha Khanom, Betty Nuako Bandoh, Hongxiang Liu, Shih-Sung Chuang. Composite Lymphoma after Chemotherapy with Regressed Diffuse Large B-cell Lymphoma and Transformed Cytotoxic T-cell Lymphoma. Leukmia & Lymphoma 2013;54(5):1101-1104. 5 year impact factor: 2.755 (2016/2017), 3.093 (2015), 2.891 (2014), 2.605 (2013), 2.301 (2012).

24. NIU Qian, SUN Qin-nuan, LI Hai-yan, LIU Hong-gang, YE Hong-tao, ZHOU Xiao-ge, GAO Zi-fen, GONG Li-ping. A20 and TNF genes aberration in ocular adnexal MALT lymphomas. Journal of Leukemia & Lymphoma 2012;21(3):141-144. (paper in Chinese). 5 year impact factor: not available.  

25. Takeshi Kashima, Dina Halai, Hongtao Ye, Sandra Nalini Hing, David Delaney, Robin Pollock, Paul O’Donnell, Roberto Tirabosco, Adrienne Margaret Flanagan. Sensitivity of MDM2 amplification and unexpected multiple faint alphoid 12 (alpha 12 satellite sequences) signals in atypical lipomatous tumor. Modern Pathology 2012;25(10):1384-1396.  5 year impact factor: 5.728 (2016/2017), 5.485 (2015), 6.187 (2014), 6.364 (2013), 5.253 (2012).

26. Gehong Dong, Yuanxue Huang, Qingguo Yan, Estelle Chanudet, Hongtao Ye, Hongxiang Liu, Peter G Isaacson, Manuel Rodriquez-Justo, Ming-Qing Du. A rare case of gastric MALT lymphoma resistant to multiple treatment regimens. Journal of Clinical Pathology 2012;65(11):1049-1050.  5 year impact factor: 2.687 (2016/2017), 2.912 (2015), 2.915 (2014), 2.551 (2013), 2.439 (2012).

27. Shih-Chuan Hsiao, Inmaculada Ribera Cortada, Hongtao Ye, Hongxiang Liu, Szu-Yin Kuo, Shu-Hui Lin, Sheng-Tsung Chang, Ted U. Kuo, Elias Campo, Shih-Sung Chuang. SOX11 is Useful in Differentiating Cyclin D1-Positive Diffuse Large B-cell Lymphoma from Mantle Cell Lymphoma. Histopathology 2012;61(4):685-693.  5 year impact factor: 3.523 (2016/2017), 3.425 (2015), 3.453 (2014), 3.301 (2013), 2.857 (2012).

28. Mikhail Lomonosov, EI Kahina Meziane, Hongtao Ye, Wenyan Zhang, Heike Laman. The Expression of Fbxo7 in Haematopoietic Progenitor Cells cooperates with p53 Loss to Promote Lymphomagenesis. PLos ONE 2011;6(6):e21165. 5 year impact factor: 2.806 (2016/2017), 4.411 (2015), 3.234 (2014), 3.534 (2013), 3.73 (2012).

29. Martin J.S. Dyer, Hongtao Ye, Peter G. Isaacson. Primary lymphoma-like lesions of the uterine cervix; a sheep in wolves’ clothing. British Journal of Haematology 2011;153(6):791-794. 5 year impact factor: 5.67 (2016/2017), 5.401 (2015), 4.711 (2014), 4.959 (2013), 4.942 (2012).

亚伯体育_官网 澳门沙巴官网游-亚伯体育 澳门沙巴官网游-亚伯体育 bodog体育-开户官网 Dota2外围|平台 澳门沙巴官网游-亚伯体育 万博体育max官网|网页版登录